Live feed05:15:00·610dPRReleasevia QuantisnowZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung CancerByQuantisnow·Wall Street's wire, on your screen.ZLAB· Zai Lab LimitedHealth Care
